PATENT CLAIM ANALYSIS

Application Number: 15918868
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["544", "359000"]

Abstract:
The present invention is related to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)propanamide which is an NK-1 antagonist useful in the treatment of induced vomiting and other disorders.

Claim (Index 3):
The crystalline form of  claim 1 , having an X-ray powder diffraction pattern comprising the following peaks, in terms of 2\u03b8: 4.5\u00b0+0.2\u00b0; 11.5\u00b0+0.2\u00b0; and 13.1\u00b0+0.2\u00b0.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.27778
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14865370', '12970785', '15150999', '13457867', '14381289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6996621681166292
- 35 USC 102 Novelty (BERT): 0.4894831800840272
- Combined Prediction Score: 0.678644269313369
- Mean Citation Score: 241.730324
- Max Citation Score: 251.20502
- Similarity Product: 218.3108970401501

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test